Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Oncolytics Biotech signs $20m share purchase deal with Alumni Capital to advance pelareorep development
Oncolytics Biotech inks $20M share deal with Alumni Capital to support pelareorep trials in breast and pancreatic cancer. Read how the biotech firm is advancing. Read More
Brazil opens doors to OneSource’s GLP-1 drugs as Bengaluru plant gets ANVISA nod
OneSource earns ANVISA GMP nod for Bengaluru plant, unlocking Brazil’s fast-growing market for GLP-1 biologics. Find out how it boosts global CDMO reach. Read More
Aurobindo Pharma wins key FDA approval for blockbuster blood thinner in $8.5bn US market
Aurobindo Pharma gets USFDA final approval for Rivaroxaban 2.5mg and tentative nod for other doses. Find out what this means for its US market strategy. Read More
Zydus wins FDA nod for DMD drug Jaythari—what it means for rare disease treatment and its stock
Find out how Zydus Lifesciences is expanding rare disease care and investor value with USFDA-approved Jaythari tablets for Duchenne muscular dystrophy. Read More
Novartis dodges Trump’s drug tariff blitz with $23bn US reshoring plan
Find out how Novartis plans to produce all key medicines in the US through a $23B investment in 10 new and expanded facilities nationwide. Read More
PharmaLogic announces strategic expansion with Agilera deal amid rising demand for nuclear medicine
PharmaLogic moves to acquire Agilera, boosting global radiopharmaceutical CDMO leadership. Find out how this deal reshapes therapeutic manufacturing worldwide. Read More
Granules India completes Senn Chemicals acquisition to expand peptide therapeutics and CDMO services
Find out how Granules India is entering peptide therapeutics and CDMO services with its Swiss acquisition of Senn Chemicals. Read More
Could this malaria drug become a breakthrough babesiosis cure? Yale and 60 Degrees aim to find out
Find out how 60 Degrees Pharmaceuticals and Yale are working to develop tafenoquine as a treatment for babesiosis, a rising tick-borne disease threat. Read More
Trump’s pharma tariff bombshell: Will your medications get more expensive?
Trump targets global drugmakers with tariffs to boost U.S. manufacturing—but could prices soar? Find out what this move means for pharma and public health. Read More
Avidity Biosciences’ del-desiran granted orphan drug designation in Japan for myotonic dystrophy type 1
Find out how Avidity Biosciences' del-desiran could transform treatment for myotonic dystrophy type 1 after securing Japan's first Orphan Drug nod for DM1. Read More